IVF Breakthrough: Is Partial Zona Dissection the Key to Higher Pregnancy Rates?
"Explore how a refined mechanical technique in preimplantation genetic diagnosis (PGD) could significantly improve your chances of a successful IVF outcome."
For couples undergoing in vitro fertilization (IVF) with preimplantation genetic diagnosis (PGD), the journey can be filled with hope and anticipation, but also with questions about the best techniques to maximize success. PGD allows for the screening of embryos for genetic abnormalities before implantation, increasing the chances of a healthy pregnancy. But what methods are used to access the cells needed for testing, and how do these methods impact the embryo's viability and the overall success of IVF?
Traditionally, accessing embryonic cells for PGD involves either chemical methods, using an acidified solution to 'drill' through the zona pellucida (the outer shell of the embryo), or mechanical methods, where a small opening is carefully created. Each approach has its proponents, but concerns exist regarding the potential harmful effects of chemicals on delicate embryos, as well as the skill required for precise mechanical manipulation.
Now, new research sheds light on a potentially superior mechanical technique: Partial Zona Dissection (PZD). This refined approach focuses on carefully creating a small slit in the zona pellucida to extract a cell, and it is showing promising results in terms of embryo development and pregnancy rates. Let's delve into the study and explore the benefits of PZD.
Partial Zona Dissection (PZD): A Gentler Approach to Embryo Biopsy?
The study, published in the journal Clinical and Experimental Reproductive Medicine, compared the outcomes of PGD using two different methods: zona drilling with acidified Tyrode's solution (chemical ZD) and Partial Zona Dissection (PZD). Researchers retrospectively analyzed 85 PGD cycles from 71 couples, evaluating blastocyst formation, hatching rates, clinical pregnancy rates, ongoing pregnancy rates, implantation rates, and fetal gender ratios.
- Higher clinical pregnancy rates (40.7% vs. 15.4%)
- Higher ongoing pregnancy rates (35.6% vs. 11.5%)
- Higher implantation rates (18.1% vs. 5.7%)
- Improved blastocyst formation and hatching rates in non-transferred embryos
Assisted Hatching Techniques and Tradeoffs
A review of assisted hatching reports that non-contact diode lasers can boost implantation and successful embryo-transfer rates in ART while maintaining safety according to the cited scientific principles. A separate review of embryo manipulation reports that embryo development retardation has been associated with assisted hatching compared with laser drilling, and that some studies found lower success rates than with mechanical zona drilling. Literature also describes chemical and laser techniques for penetrating the zona pellucida during biopsy, underscoring that several approaches are in use rather than establishing partial zona dissection as the preferred method.
Retrospective Evidence Has Limits
A study comparing preimplantation genetic diagnosis outcomes after zona drilling with acidified Tyrode’s solution or partial zona dissection concluded that partial zona dissection showed better clinical outcomes in that study. The authors also noted several limitations because the study used a retrospective design. Its result therefore describes that study’s comparison and does not, on its own, establish that partial zona dissection will produce better outcomes generally.
Implications for Your IVF Journey
For couples considering IVF with PGD, these findings offer valuable insights. While zona drilling with acidified Tyrode's solution remains a viable option, Partial Zona Dissection presents a promising alternative with potentially improved outcomes. Discussing the latest research and techniques with your fertility specialist is crucial in determining the best approach for your individual circumstances.
Testing Does Not Guarantee Higher Overall Success
Preimplantation genetic diagnosis analyzes a representative sample biopsied from an IVF-derived embryo, with the stated aim of doing so without compromising embryonic viability. A review of chromosomal analysis says PGT-A is widely used to identify euploid embryos for transfer and reports that pregnancy rates per embryo transfer increase with euploid embryo transfer, while success per ovum pickup does not. However, a 2024 review says the value of PGT-A as a routine screening test for all IVF patients has not been demonstrated. Together, these sources distinguish a reported benefit per transfer from proof of routine benefit for every patient.
A Growing and Evolving Testing Market
One market report projects the preimplantation genetic diagnosis market will reach $3.7 billion by 2033, attributing growth to advances in IVF and next-generation sequencing technologies. It names Illumina, Thermo Fisher, and Abbott among key players. Another 2026 report describes the PGD market as driven by reproductive-technology advances and demand for healthy pregnancies, and identifies Roche, Illumina, and Natera as key players. These are market projections and descriptions, not evidence that a particular zona-dissection technique improves pregnancy outcomes.
Benefits and Uncertainties in Genetic Testing
PGS uses methods from PGD to screen IVF embryos for their potential to implant, and a review highlights its relevance in male infertility, advanced maternal age, and recurrent miscarriage. Yet a 2007 report on a European study said screening embryos for chromosome abnormalities reduced IVF success rates by nearly a third in older women. Another source notes that PGT is among the most invasive ART procedures and that only a limited number of studies have investigated associated neonatal outcomes. These sources present potential uses alongside reported limitations and remaining evidence gaps.
Outcomes Vary by Treatment Indication
A 2025 study reports that people accessing preimplantation genetic testing for monogenic conditions had higher clinical pregnancy and live birth rates than couples undergoing IVF for other indications, such as subfertility. The supplied excerpt does not provide the size of this difference or establish why the groups differed. A separate 2021 study describes its aim as addressing controversies in interpreting promising IVF results with preimplantation genetic screening, but the available excerpt does not state its findings. These reports therefore offer context on outcomes and ongoing debate, not a direct comparison of partial zona dissection with other methods.
It's important to remember that IVF success depends on many factors, including patient age, embryo quality, and the expertise of the clinical team. However, by staying informed about innovative techniques like PZD, you can actively participate in optimizing your chances of a successful outcome.
While this study provides compelling evidence for the benefits of PZD, further prospective research is needed to confirm these findings and explore the long-term effects of different biopsy methods. As the field of reproductive medicine continues to advance, staying informed and proactive will empower you to make the best decisions for your fertility journey.